Evelo Biosciences, Inc.
EVLO · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $1 | $18 | $20 | $177 |
| - Cash | $17 | $8 | $27 | $48 |
| + Debt | $34 | $50 | $51 | $51 |
| Enterprise Value | $17 | $61 | $43 | $180 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$1 | -$2 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$11 | -$19 | -$24 | -$21 |
| % Margin | – | – | – | – |
| Net Income | -$12 | -$21 | -$25 | -$24 |
| % Margin | – | – | – | – |
| EPS Diluted | -71.12 | -3.78 | -4.57 | -4.29 |
| % Growth | -1,781.5% | 17.3% | -6.5% | – |
| Operating Cash Flow | -$10 | -$20 | -$20 | -$23 |
| Capital Expenditures | -$0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$10 | -$20 | -$20 | -$23 |